Search Orphan Drug Designations and Approvals
-
| Generic Name: | Recombinant human signal regulating protein alpha (SIRPalpha) fragment crystallizable (Fc)-fusion protein |
|---|---|
| Date Designated: | 11/07/2023 |
| Orphan Designation: | Treatment of chronic myelomonocytic leukemia |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Building 15, Lane 1000, Zhangheng Road Free Trade Zone Shanghai 201203 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







